Zhang et al. revealed that sEVs could deliver lncRNA SBF2-AS1 from TMZ-resistant glioma cells to TMZ-sensitive glioma cells to spread TMZ resistance in glioma. This evidence concerns the gene SBF2 and central nervous system cancer.